Ketolac 30 mg / 2 ml 5 amp

Ketolac

Each 2 ml ampoule contains:

Ketorolac tromethamine 30 mg

Auxiliary components:

sodium chloride, disodium edetate, water for injection.

Ketorolac is an NSAID that has a pronounced analgesic (analgesic) effect, also has an anti-inflammatory and moderate antipyretic effect.

Ketorolac does not affect opioid receptors, does not depress respiration, does not cause drug dependence, does not have a sedative and anxiolytic effect.

The strength of the analgesic (pain-relieving) effect is comparable to that of morphine, significantly superior to other NSAIDs.

After intramuscular administration, the onset of the analgesic (anesthetic) action is noted after 0.5 hours, the maximum effect is achieved after 1-2 hours.

Pain syndrome of severe and moderate severity: trauma, toothache, pain in the postoperative period, cancer, myalgia, arthralgia, neuralgia, sciatica, dislocations, sprains, rheumatic diseases.

Designed for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease.

The drug should be injected deeply in / m or in / in (jet) slowly for at least 15 seconds in the minimum effective doses, selected in accordance with the intensity of pain and the patient’s response. If necessary, you can additionally prescribe opioid analgesics in reduced doses at the same time.

Single doses for a single intramuscular or intravenous injection: adults under the age of 65 – 10-30 mg, depending on the severity of the pain syndrome; elderly patients over 65 years of age or with impaired renal function – 10-15 mg.

Doses for multiple parenteral administration:

For intramuscular administration, adults under the age of 65 and children over 16 years of age are injected intramuscularly 10-60 mg in the first administration, then 10-30 mg every 6 hours (usually 30 mg every 6 hours); elderly patients over 65 years of age or with impaired renal function – 10-15 mg every 4-6 hours.

– complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses and intolerance to acetylsalicylic acid or other NSAIDs;

– urticaria, rhinitis caused by taking NSAIDs;

– intolerance to drugs of the pyrazolone series;

-dehydration, hypovolemia;

– bleeding or high risk of their development;

– condition after coronary artery bypass grafting;

-confirmed hyperkalemia;

-inflammatory bowel disease;

– erosive and ulcerative lesions of the gastrointestinal tract in the acute stage, peptic ulcers;

-hypocoagulation;

– severe renal failure;

– severe liver failure or active liver disease;

– hemorrhagic stroke;

– hemorrhagic diathesis;

– violation of hematopoiesis;

-pregnancy;

– childbirth;

-period of lactation (breastfeeding);

-Children under 16 years old.

To reduce the risk of developing NSAID gastropathy, antacids, misoprostol, omeprazole are prescribed.

From the side of the central nervous system and peripheral nervous system: often – headache, dizziness, drowsiness.

On the part of the digestive system: often (especially in elderly patients over 65 years of age with a history of erosive and ulcerative lesions of the gastrointestinal tract) – gastralgia, diarrhea; less often – stomatitis, flatulence, constipation, vomiting, a feeling of fullness in the stomach.

Store at a temperature not exceeding 30 degrees.

The cardboard box contains 5 ampoules of 2 ml, paper instructions.